{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T06:00:41Z","timestamp":1789365641192,"version":"build-2803163510"},"update-to":[{"DOI":"10.1002\/14651858.cd009061","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2015,9,4]],"date-time":"2015-09-04T00:00:00Z","timestamp":1441324800000}}],"reference-count":107,"publisher":"Wiley","issue":"9","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd009061.pub2","type":"journal-article","created":{"date-parts":[[2015,9,4]],"date-time":"2015-09-04T08:41:03Z","timestamp":1441356063000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Systemic antibiotics for treating diabetic foot infections"],"prefix":"10.1002","volume":"2015","author":[{"given":"Anna","family":"Selva Olid","sequence":"first","affiliation":[{"name":"Biomedical Research Institute Sant Pau (IIB-Sant Pau); Iberoamerican Cochrane Centre; C. Sant Antoni Maria Claret 167 Pavell\u00f3 18 I Planta 0 Barcelona Spain 08025"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Sol\u00e0","sequence":"additional","affiliation":[{"name":"CIBER Epidemiolog\u00eda y Salud P\u00fablica (CIBERESP) - Universitat Aut\u00f2noma de Barcelona; Iberoamerican Cochrane Centre - Biomedical Research Institute Sant Pau (IIB Sant Pau); Sant Antoni Maria Claret 171 - Edifici Casa de Convalesc\u00e8ncia Barcelona Catalunya Spain 08041"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leticia A","family":"Barajas-Nava","sequence":"additional","affiliation":[{"name":"Health National Institute, Hospital Infantil de M\u00e9xico Federico Gomez (HIMFG). Iberoamerican Cochrane Network; Evidence-Based Medicine Research Unit; Dr. Marquez #162 Col. Doctores, Del. Cuahutemoc M\u00e9xico City Mexico 06720"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar D","family":"Gianneo","sequence":"additional","affiliation":[{"name":"Fondo Nacional de Recursos; Centro Colaborador Cochrane; 18 de Julio 985-Galeria Cristal Cuarto Piso Julian Laguna 4213 Montevideo Uruguay 11100"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Bonfill Cosp","sequence":"additional","affiliation":[{"name":"CIBER Epidemiolog\u00eda y Salud P\u00fablica (CIBERESP) - Universitat Aut\u00f2noma de Barcelona; Iberoamerican Cochrane Centre - Biomedical Research Institute Sant Pau (IIB Sant Pau); Sant Antoni Maria Claret 171 - Edifici Casa de Convalesc\u00e8ncia Barcelona Catalunya Spain 08041"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin A","family":"Lipsky","sequence":"additional","affiliation":[{"name":"University of Washington; Department of Medicine; Seattle Washington USA 98108-1597"},{"name":"University of Geneva; Department of Infectious Diseases; Geneva Switzerland"},{"name":"University of Oxford; Division of Medical Sciences; Oxford UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,9,4]]},"reference":[{"key":"10.1002\/14651858.CD009061.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1086\/420818","article-title":"The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections","volume":"38","author":"Arbeit","year":"2004","journal-title":"Clinical Infectious Diseases"},{"key":"10.1002\/14651858.CD009061.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1093\/jac\/dkh531","article-title":"Daptomycin for treating infected diabetic foot ulcers: evidence from a randomized, controlled trial comparing daptomycin with vancomycin or semi-synthetic penicillins for complicated skin and skin-structure infections","volume":"55","author":"Lipsky","year":"2005","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"10.1002\/14651858.CD009061.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0924-8579(96)00305-6","article-title":"Treatment of diabetic foot infection: an open randomised comparison of imipenem\/cilastatin and piperacillin\/clindamycin combination therapy","volume":"7","author":"Bouter","year":"1996","journal-title":"International Journal of Antimicrobial Agents"},{"issue":"3","key":"10.1002\/14651858.CD009061.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.amjopharm.2004.09.006","article-title":"Clinical efficacy, tolerability, and cost savings associated with the use of open-label metronidazole plus ceftriaxone once daily compared with ticarcillin\/clavulanate every 6 hours as empiric treatment for diabetic lower-extremity Infections in older males","volume":"2","author":"Clay","year":"2004","journal-title":"The American Journal of Geriatric Pharmacotherapy"},{"issue":"4","key":"10.1002\/14651858.CD009061.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1177\/153857449703100403","article-title":"Prospective, randomized comparison of ampicillin\/sulbactam and cefoxitin for diabetic foot infections","volume":"31","author":"Erstad","year":"1997","journal-title":"Vascular Surgery"},{"key":"10.1002\/14651858.CD009061.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.ijantimicag.2005.07.017","article-title":"Sequential intravenous\/oral moxifloxacin versus intravenous pipreacillin-tazobactam followed by oral amoxicillin-clavulanate for the treatment of complicated skin and skin structure infection","volume":"26","author":"Giordano","year":"2005","journal-title":"International Journal of Antimicrobial Agents"},{"key":"10.1002\/14651858.CD009061.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1086\/340348","article-title":"Ertapenem once daily versus piperacillin-tazobactam 4 times per day for treatment of complicated skin and skin-structure infections in adults: results of a prospective, randomized, double-blind multicenter study","volume":"34","author":"Graham","year":"2002","journal-title":"Clinical Infectious Disease"},{"key":"10.1002\/14651858.CD009061.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1086\/341026","article-title":"Once-daily, high-dose levofloxacin versus ticarcillin-clavulanate alone or followed by amoxicillin-clavulanate for complicated skin and skin-structure infections: a randomized, open-label trial","volume":"35","author":"Graham","year":"2002","journal-title":"Clinical Infectious Diseases"},{"key":"10.1002\/14651858.CD009061.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1093\/clinids\/18.5.683","article-title":"Use of ampicillin\/sulbactam versus imipenem\/cilastatin in the treatment of limb-threatening foot infections in diabetic patients","volume":"18","author":"Grayson","year":"1994","journal-title":"Clinical Infectious Disease"},{"key":"10.1002\/14651858.CD009061.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/clinids\/24.1.57","article-title":"Cost-effectiveness ofaAmpicillin\/sulbactam versus imipenem\/cilastatin in the treatment of limb-threatening foot infections in diabetic patients","volume":"24","author":"McKinnon","year":"1997","journal-title":"Clinical Infectious Disease"},{"key":"10.1002\/14651858.CD009061.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1089\/sur.2005.6.27","article-title":"An open-label, randomized study comparing efficacy and safety of intravenous piperacillin\/tazobactam and ampicillin\/sulbactam for infected diabetic foot ulcers","volume":"6","author":"Harkless","year":"2005","journal-title":"Surgical Infections"},{"key":"10.1002\/14651858.CD009061.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.diagmicrobio.2013.12.007","article-title":"Phase 3 study comparing tigecycline and ertapenem in patients with diabetic foot infections with and without osteomyelitis","volume":"78","author":"Lauf","year":"2014","journal-title":"Diagnostic Microbiology and Infectious Disease"},{"key":"10.1002\/14651858.CD009061.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1001\/archinte.1990.00390160058013","article-title":"Outpatient management of uncomplicated lower-extremity infections in diabetic patients","volume":"150","author":"Lipsky","year":"1990","journal-title":"Archives of Internal Medicine"},{"key":"10.1002\/14651858.CD009061.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1093\/clind\/24.4.643","article-title":"Antibiotic therapy for diabetic foot infections: comparison of two parenteral-to-oral regimens","volume":"24","author":"Lipsky","year":"1997","journal-title":"Clinical Infectious Diseases"},{"key":"10.1002\/14651858.CD009061.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1086\/380449","article-title":"Treating foot infections in diabetic patients: a randomized, multicenter, open-label trial of linezolid versus ampicillin-sulbactam\/amoxicillin-clavulanate","volume":"38","author":"Lipsky","year":"2004","journal-title":"Clinical Infectious Disease"},{"key":"10.1002\/14651858.CD009061.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1086\/526527","article-title":"A randomized, double-blind trial comparing ceftobiprole medocaril with vancomycin plus ceftazidime for the treatment of patients with complicated skin and skin-structure infections","volume":"46","author":"Noel","year":"2008","journal-title":"Clinical Infectious Diseases"},{"key":"10.1002\/14651858.CD009061.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1093\/jac\/dkr344","article-title":"A randomized trial of the efficacy and safety of sequential intravenous\/oral moxifloxacin monotherapy versus intravenous piperacillin\/tazobactam followed by oral amoxicillin\/clavulanate for complicated skin and skin structure infections","volume":"66","author":"Gynssens","year":"2011","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"10.1002\/14651858.CD009061.pub2-BIB0018|cit18","first-page":"462","article-title":"Efficacy of moxifloxacin in the treatment of diabetic foot infections: results of the RELIEF study","volume":"53 Suppl1","author":"Schaper","year":"2010","journal-title":"Diabetologia"},{"key":"10.1002\/14651858.CD009061.pub2-BIB0019|cit19","first-page":"1252","article-title":"Piperacillin\/tazobactam versus imipenem\/cilastatin for severe diabetic foot infections: a prospective, randomized clinical trial in a university hospital","volume":"16","author":"Saltoglu","year":"2010","journal-title":"Infectious Diseases"},{"issue":"2","key":"10.1002\/14651858.CD009061.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1128\/AAC.45.2.525-531.2001","article-title":"Clinafloxacin versus piperacillin-tazobactam in treatment of patients with severe skin and soft tissue infections","volume":"45","author":"Siami","year":"2001","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1002\/14651858.CD009061.pub2-BIB0021|cit21","unstructured":"Abramson MA The SIDESTEP study of diabetic foot infections (DFI): a multicenter,double-blinded, randomized, controlled trial (RCT) of ertapenem (E)v s. piperacillin\/tazobactam (P\/T) Diabetologia 2005 A81 2"},{"key":"10.1002\/14651858.CD009061.pub2-BIB0022|cit22","unstructured":"Lipsky BA Armstrong D Citron D Halperin GJ Sheehan P Tice A The SIDESTEP study of diabetic foot infections (DFI): a multicenter, double-blinded, randomized, controlled trial (RCT) of ertapenem (E) vs. piperacillin\/tazobactam (P\/T) Society of Hospital Medicine 2005 Annual Meeting Abstracts 28"},{"key":"10.1002\/14651858.CD009061.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/S0140-6736(05)67694-5","article-title":"Ertapenem versus piperacillin\/tazobactam for diabetic foot infections (SIDESTEP): prospective, randomised, controlled, double-blinded, multicentre trial","volume":"366","author":"Lipsky","year":"2005","journal-title":"Lancet"},{"issue":"5","key":"10.1002\/14651858.CD009061.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s15010-009-8468-x","article-title":"Efficacy and safety of sequential intravenous\/oral moxifloxacin vs intravenous\/oral amoxicillin\/clavulanate for complicated skin and skin structure infections","volume":"37","author":"Vick-Fragoso","year":"2009","journal-title":"Infection"},{"issue":"8","key":"10.1002\/14651858.CD009061.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1128\/AAC.37.8.1580","article-title":"Treatment of hospitalized patients with complicated skin and skin structure infections: double-blind, randomized, multicenter study of piperacillin-tazobactam versus ticarcillin-clavulanate","volume":"37","author":"Tan","year":"1993","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"8","key":"10.1002\/14651858.CD009061.pub2-BIB0026|cit26","first-page":"881","article-title":"Antibiotic treatment for diabetic foot. Advantages of intravenous regional route as alternative for systemic route","volume":"118","author":"Acevedo","year":"1990","journal-title":"Revista M\u00e9dica de Chile"},{"key":"10.1002\/14651858.CD009061.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1179\/joc.1996.8.4.284","article-title":"Efficacy of sulbactam-ampicillin for the treatment of severe diabetic foot infections","volume":"8","author":"Akova","year":"1996","journal-title":"Journal of Chemotherapy (Florence, Italy)"},{"issue":"3","key":"10.1002\/14651858.CD009061.pub2-BIB0028|cit28","first-page":"490","article-title":"Management of diabetic foot in a Jordanian hospital","volume":"11","author":"Al-Ebous","year":"2005","journal-title":"La Revue de Sant\u00e9 de la M\u00e9diterran\u00e9e Orientale"},{"key":"10.1002\/14651858.CD009061.pub2-BIB0029|cit29","first-page":"1163","article-title":"Prospective study of the efficacy and safety or oral and intravenous ciprofloxacin in the treatment of diabetic foot infections","volume":"11 Suppl 5","author":"Beam","year":"1989","journal-title":"Reviews of Infectious Diseases"},{"key":"10.1002\/14651858.CD009061.pub2-BIB0030|cit30","first-page":"63","article-title":"Ceftriaxone treatment of skin and soft tissue infections in a once daily regimen","volume":"19","author":"Bradsher","year":"1984","journal-title":"The American Journal of Medicine"},{"issue":"7","key":"10.1002\/14651858.CD009061.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1128\/AAC.00206-07","article-title":"Prospective randomized trial of empiric therapy with trimethoprim-sulfamethoxazole or doxycycline for outpatient skin and soft tissue infections in an area of high prevalence of methicillin-resistant Staphylococcus aureus","volume":"51","author":"Cenizal","year":"2007","journal-title":"Antimicrobial Agents and Chemotherapy\u00a0"},{"key":"10.1002\/14651858.CD009061.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/(SICI)1096-9136(199602)13:2<156::AID-DIA59>3.0.CO;2-U","article-title":"Antibiotic treatment for uncomplicated neuropathic forefoot ulcers in diabetes: a controlled trial","volume":"13","author":"Chantelau","year":"1996","journal-title":"Diabetic Medicine"},{"key":"10.1002\/14651858.CD009061.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1111\/ijcp.12174","article-title":"Sequential intravenous\/oral moxifloxacin monotherapy for complicated skin and skin structure infections: A meta-analysis of randomised controlled trials","volume":"67","author":"Chen","year":"2013","journal-title":"International Journal of Clinical Practice"},{"key":"10.1002\/14651858.CD009061.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.ijid.2011.05.003","article-title":"Diabetic foot infection: a critical review of recent randomized clinical trials on antibiotic therapy","volume":"15","author":"Crouzet","year":"2011","journal-title":"International Journal of Infectious Diseases"},{"key":"10.1002\/14651858.CD009061.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"288","DOI":"10.2165\/00003495-199958002-00096","article-title":"Comparison of the efficacy and safety of once-daily oral trovafloxacin and 3-times-daily amoxicillin\/clavulanic acid for the treatment of complicated skin and soft-tissue infections","volume":"58 Suppl 2","author":"Daniel","year":"1999","journal-title":"Drugs"},{"issue":"1","key":"10.1002\/14651858.CD009061.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"101","DOI":"10.5144\/0256-4947.1993.101a","article-title":"Management of diabetic foot lesions with limited use of antibiotics","volume":"13","author":"Darwish","year":"1993","journal-title":"Annals of Saudi Medicine"},{"key":"10.1002\/14651858.CD009061.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.diagmicrobio.2008.03.004","article-title":"The efficacy and safety of ceftobiprole in the treatment of complicated skin and skin structure infections: evidence from 2 clinical trials","volume":"61","author":"Deresinski","year":"2008","journal-title":"Diagnostic Microbiology and Infectious Disease"},{"key":"10.1002\/14651858.CD009061.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0002-9610(03)00300-3","article-title":"The use of antibiotics in the diabetic foot","volume":"187 Suppl 5A","author":"Edmonds","year":"2004","journal-title":"American Journal of Surgery"},{"issue":"8","key":"10.1002\/14651858.CD009061.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/j.clinthera.2006.08.008","article-title":"A post hoc subgroup analysis of meropenem versus imipenem\/cilastatin in a multicenter, double-blind, randomized study of complicated skin and skin-structure infections in patients with diabetes mellitus","volume":"28","author":"Embil","year":"2006","journal-title":"Clinical Therapeutics"},{"issue":"5","key":"10.1002\/14651858.CD009061.pub2-BIB0040|cit40","first-page":"200","article-title":"Antibiotic treatment in patients amputated for ischemic diabetic foot","volume":"43","author":"Fern\u00e1ndez","year":"1991","journal-title":"Angiologia"},{"key":"10.1002\/14651858.CD009061.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/0002-9343(83)90103-1","article-title":"Amdinocillin plus cefoxitin versus cefoxitin alone in therapy of mixed soft tissue infections (including diabetic foot infections)","volume":"29","author":"File","year":"1983","journal-title":"The American Journal of Medicine"},{"key":"10.1002\/14651858.CD009061.pub2-BIB0042|cit42","first-page":"51","article-title":"Efficacy and safety of piperacillin\/tazobactam in skin and soft tissue infections","volume":"Suppl 573","author":"File","year":"1994","journal-title":"European Journal of Surgery"},{"key":"10.1002\/14651858.CD009061.pub2-BIB0043|cit43","first-page":"10","article-title":"Should oral antibiotics be given to \"clean\" foot ulcers with no cellulitis?","volume":"15 Suppl 2","author":"Foster","year":"1998","journal-title":"Diabetic Medicine"},{"key":"10.1002\/14651858.CD009061.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1001\/archinte.1989.00390110127028","article-title":"Oral ciprofloxacin vs parenteral cefotaxime in the treatment of difficult skin and skin structure infections","volume":"149","author":"Gentry","year":"1989","journal-title":"Archives of Internal Medicine"},{"key":"10.1002\/14651858.CD009061.pub2-BIB0045|cit45","first-page":"57","article-title":"A comparative evaluation of oral ofloxacin versus intravenous cefotaxime therapy for serious skin and skin structure infections","volume":"87 Suppl 6C","author":"Gentry","year":"1989","journal-title":"The American Journal of Medicine"},{"key":"10.1002\/14651858.CD009061.pub2-BIB0046|cit46","first-page":"36","article-title":"Treatment and long-term follow-up of foot infections in patients with diabetes or ischemia: a randomized, prospective, double-blind\u00a0 comparison of cefoxitin and ceftizoxime","volume":"10 Suppl A","author":"Hughes","year":"1987","journal-title":"Clinical Therapeutics"},{"key":"10.1002\/14651858.CD009061.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.amjsurg.2009.08.045","article-title":"Efficacy and safety of linezolid versus vancomycin for the treatment of complicated skin and soft-tissue infections proven to be caused by methicillin resistant Staphylococcus aureus","volume":"199","author":"Itani","year":"2010","journal-title":"American Journal of Surgery"},{"key":"10.1002\/14651858.CD009061.pub2-BIB0048|cit48","first-page":"329","article-title":"Efficacy and tolerability of a combination of ofloxacin and tinidazole in the management of infectious diabetic foot ulcer","volume":"101","author":"Joshi","year":"2003","journal-title":"Journal of the Indian Medical Association"},{"key":"10.1002\/14651858.CD009061.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ijid.2010.10.003","article-title":"The role of diabetes mellitus in the treatment of skin and skin structure infections caused by methicillin-resistant Staphylococcus aureus: results from three randomized controlled trials","volume":"15","author":"Lipsky","year":"2011","journal-title":"International Journal of Infectious Diseases"},{"issue":"4","key":"10.1002\/14651858.CD009061.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0149-2918(00)88319-8","article-title":"Sparfloxacin versus ciprofloxacin for the treatment of community-acquired, complicated skin and skin-structure infections","volume":"21","author":"Lipsky","year":"1999","journal-title":"Clinical Therapeutics"},{"issue":"4","key":"10.1002\/14651858.CD009061.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1464-5491.2006.01785.x","article-title":"Systematic review of antimicrobial treatments for diabetic foot ulcers","volume":"23","author":"Nelson","year":"2006","journal-title":"Diabetic Medicine\u00a0"},{"issue":"1","key":"10.1002\/14651858.CD009061.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1128\/AAC.00551-07","article-title":"Results of a double-blind, randomized trial of ceftobiprole treatment of complicated skin and skin structure infections caused by Gram-positive bacteria","volume":"52","author":"Noel","year":"2008","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1002\/14651858.CD009061.pub2-BIB0053|cit53","first-page":"242","article-title":"Double-blind comparison of ciprofloxacin with cefotaxime in the treatment of skin and skin structure infections","volume":"82 Suppl 4A","author":"P\u00e9rez-Ruvalcaba","year":"1987","journal-title":"The American Journal of Medicine"},{"key":"10.1002\/14651858.CD009061.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/dmrr.2247","article-title":"A systematic review of the effectiveness of interventions in the management of infection in the diabetic foot","volume":"28 Suppl 1","author":"Peters","year":"2012","journal-title":"Diabetes\/Metabolism Research and Reviews"},{"key":"10.1002\/14651858.CD009061.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/0002-9343(89)90476-2","article-title":"Therapy of lower extremity infections with ciprofloxacin in patients with diabetes mellitus, peripheral vascular disease, or both","volume":"86","author":"Peterson","year":"1989","journal-title":"The American Journal of Medicine"},{"key":"10.1002\/14651858.CD009061.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0149-2918(02)85005-6","article-title":"Cinafloxacin versus piperacillin\/tazobactam in the treatment of severe skin and soft-tissue infections in adults at a veterans affairs medical center","volume":"24","author":"Siami","year":"2002","journal-title":"Clinical Therapeutics"},{"key":"10.1002\/14651858.CD009061.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0002-9343(85)90148-2","article-title":"Ticarcillin plus clavulanic acid versus moxalactam therapy of osteomyelitis, septic arthritis, and skin and soft tissue infections","volume":"79 Suppl 5B","author":"Siebert","year":"1985","journal-title":"The American Journal of Medicine"},{"key":"10.1002\/14651858.CD009061.pub2-BIB0058|cit58","first-page":"P","article-title":"Prospective, controlled, randomized, evaluator-blind, comparative study of oral ciprofloxacin with and without oral metronidazole versus intravenous ticarcillin\/clavulanic acid followed by oral amoxicillin\/clavulanic acid in the treatment of diabetic foot infections","volume":"27","author":"Smith","year":"1992","journal-title":"ASHP Midyear Clinical Meeting\u00a0"},{"key":"10.1002\/14651858.CD009061.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S0002-9343(20)31156-6","article-title":"Comparison of oral fleroxacin with oral amoxicillin\/clavulanate for treatment of skin and soft tissue infections","volume":"94 Suppl 3A","author":"Smith","year":"1993","journal-title":"The American Journal of Medicine"},{"key":"10.1002\/14651858.CD009061.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s101560050006","article-title":"Teicoplanin for skin and soft tissue infections: an open study and a randomized, comparative trial versus cefazolin","volume":"5","author":"Stevens","year":"1999","journal-title":"Journal of Infection and Chemotherapy"},{"issue":"12","key":"10.1002\/14651858.CD009061.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1128\/AAC.44.12.3408-3413.2000","article-title":"Randomized comparison of linezolid (PNU-100766) versus oxacillin-dicloxacillin for treatment of complicated skin and soft tissue infections","volume":"44","author":"Stevens","year":"2000","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1002\/14651858.CD009061.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1086\/340353","article-title":"Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections","volume":"34","author":"Stevens","year":"2002","journal-title":"Clinical Infectious Diseases"},{"key":"10.1002\/14651858.CD009061.pub2-BIB0063|cit63","first-page":"102","article-title":"[Vasin new fluoroquinolones in treatment of patients with infectious lesions in diabetic foot syndrome]","volume":"10","author":"Stupin","year":"2014","journal-title":"Khirurgiia"},{"key":"10.1002\/14651858.CD009061.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.diabres.2008.01.009","article-title":"Factors associated with treatment failure in patients with diabetic foot infections: an analysis of data from randomized controlled trials","volume":"80","author":"Vardakas","year":"2008","journal-title":"Journal Diabetes Research and Clinical Practice"},{"key":"10.1002\/14651858.CD009061.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"2260-6","DOI":"10.1128\/AAC.49.6.2260-2266.2005","article-title":"Linezolid versus vancomycin in treatment of complicated skin and soft tissue infections","volume":"49","author":"Weigelt","year":"2005","journal-title":"Antimicrobial Agents Chemotherapy"},{"key":"10.1002\/14651858.CD009061.pub2-BIB0066|cit66","unstructured":"NCT01199783 Application of daptomycin in MRSA infected diabetic foot in comparison to vancomycin treatment clinicaltrials.gov\/show\/ NCT01199783 (accessed September 2014)"},{"key":"10.1002\/14651858.CD009061.pub2-BIB0067|cit67","unstructured":"NCT01370616 A phase III, randomized, double-blind, active comparator-controlled clinical trial to study the efficacy and safety of ertapenem sodium (MK-0826) versus piperacillin\/tazobactam sodium in the treatment of diabetic foot infections in Chinese adults clinicaltrials.gov\/show\/ NCT01370616 (accessed September 2014) 2011"},{"issue":"1","key":"10.1002\/14651858.CD009061.pub2-BIB0068|cit68","first-page":"71","article-title":"Diabetic foot infection","volume":"78","author":"Bader","year":"2008","journal-title":"American Family Physician"},{"key":"10.1002\/14651858.CD009061.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/dmrr.836","article-title":"Diabetic foot osteomyelitis: a progress report on diagnosis and a systematic review of treatment","volume":"24 Suppl 1","author":"Berendt","year":"2008","journal-title":"Diabetes\/Metabolism Research and Reviews"},{"key":"10.1002\/14651858.CD009061.pub2-BIB0070|cit70","doi-asserted-by":"crossref","unstructured":"Bero LA Why the Cochrane risk of bias tool should include funding source as a standard item [editorial] Cochrane Database of Systematic Reviews 2013","DOI":"10.1002\/14651858.ED000075"},{"issue":"4","key":"10.1002\/14651858.CD009061.pub2-BIB0071|cit71","first-page":"233","article-title":"Consensus document on treatment of infections in diabetic foot","volume":"24","author":"Blanes","year":"2011","journal-title":"Revista Espa\u00f1ola de Quimioterapia"},{"issue":"9498","key":"10.1002\/14651858.CD009061.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1016\/S0140-6736(05)67698-2","article-title":"The global burden of diabetic foot disease","volume":"366","author":"Boulton","year":"2005","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD009061.pub2-BIB0073|cit73","doi-asserted-by":"crossref","unstructured":"Bradley M Cullum N Nelson EA Petticrew M Sheldon T Torgerson D Systematic reviews of wound care management: (2) Dressings and topical agents used in the healing of chronic wounds Health Technology Assessment 1999","DOI":"10.3310\/hta3172"},{"key":"10.1002\/14651858.CD009061.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jcjd.2013.01.040","article-title":"Foot Care","volume":"37 Suppl 1","author":"Bowering","year":"2013","journal-title":"Canadian Journal of Diabetes"},{"key":"10.1002\/14651858.CD009061.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"e601","DOI":"10.1016\/j.ijid.2011.05.003","article-title":"Diabetic foot infection: a critical review of recent randomized clinical trials on antibiotic therapy","volume":"15","author":"Crouzet","year":"2011","journal-title":"International Journal of Infectious Diseases"},{"issue":"3","key":"10.1002\/14651858.CD009061.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1177\/1534734605280597","article-title":"Infection in the neuroischemic foot","volume":"4","author":"Edmondes","year":"2005","journal-title":"International Journal of Low Extremity Wounds"},{"key":"10.1002\/14651858.CD009061.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1067-2516(07)60001-5","article-title":"Diabetic foot disorders. A clinical practice guideline (2006 revision)","volume":"45 Suppl 5","author":"Frykberg","year":"2006","journal-title":"Journal of Foot and Ankle Surgery"},{"issue":"6","key":"10.1002\/14651858.CD009061.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.jclinepi.2004.09.013","article-title":"Uncertainty method improved on best-worst case analysis in a binary meta-analysis","volume":"58","author":"Gamble","year":"2005","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD009061.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD009061.pub2-BIB0080|cit80","unstructured":"Higgins JPT Altman DG Sterne JAC (editors) Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011) The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org."},{"issue":"12","key":"10.1002\/14651858.CD009061.pub2-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1093\/cid\/cis460","article-title":"Executive summary: 2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections","volume":"54:","author":"Lipsky","year":"2012","journal-title":"Clinical Infectious Diseases"},{"key":"10.1002\/14651858.CD009061.pub2-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/dmrr.2251","article-title":"Specific guidelines for the treatment of diabetic foot infections 2011","volume":"28 Suppl 1","author":"Lipsky","year":"2012","journal-title":"Diabetes\/Metabolism Research and Reviews"},{"issue":"5","key":"10.1002\/14651858.CD009061.pub2-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.2337\/diacare.26.5.1435","article-title":"Diabetic foot syndrome: evaluating the prevalence and incidence of foot pathology in Mexican Americans and non-Hispanic whites from a diabetes disease management cohort","volume":"26","author":"Lavery","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1002\/14651858.CD009061.pub2-BIB0084|cit84","unstructured":"Lefebvre C Manheimer E Glanville J on behalf of the Cochrane Information Retrieval Methods Group Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD009061.pub2-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1086\/383271","article-title":"Medical treatment of diabetic foot infections","volume":"39 Suppl 2","author":"Lipsky","year":"2004","journal-title":"Clinical Infectious Diseases"},{"issue":"7","key":"10.1002\/14651858.CD009061.pub2-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1086\/424846","article-title":"Diagnosis and treatment of diabetic foot infections","volume":"39","author":"Lipsky","year":"2004","journal-title":"Clinical Infectious Diseases"},{"issue":"2","key":"10.1002\/14651858.CD009061.pub2-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1093\/jac\/dkm130","article-title":"Treating diabetic foot infections with sequential intravenous to oral moxifloxacin compared with piperacillin-tazobactam\/amoxicillin-clavulanate","volume":"60","author":"Lipsky","year":"2007","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"Issue 3","key":"10.1002\/14651858.CD009061.pub2-BIB0088|cit88","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD011038","article-title":"Topical antimicrobial agents for preventing and treating foot infections in people with diabetes (Protocol)","author":"Lipsky","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD009061.pub2-BIB0089|cit89","first-page":"Art. No.: MR000","article-title":"Industry sponsorship and research outcome","volume":"12","author":"Lundh","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD009061.pub2-BIB0090|cit90","first-page":"142","article-title":"Recent advances in the management of gangrene and infections in patients with diabetes mellitus","volume":"13","author":"McKittrick","year":"1946","journal-title":"Journal of Digestive Diseases"},{"key":"10.1002\/14651858.CD009061.pub2-BIB0091|cit91","unstructured":"MedlinePlus US National Library of Medicine. National Institutes of Health http:\/\/www.nlm.nih.gov\/medlineplus\/"},{"issue":"12","key":"10.1002\/14651858.CD009061.pub2-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"iii-iv, ix-x, 1","DOI":"10.3310\/hta10120","article-title":"A series of systematic reviews to inform a decision analysis for sampling and treating infected diabetic foot ulcers","volume":"10","author":"Nelson","year":"2006","journal-title":"Health Technology Assessment"},{"key":"10.1002\/14651858.CD009061.pub2-BIB0093|cit93","unstructured":"National Institute for Health and Clinical Excellence NICE clinical guideline 119. Diabetic foot problems. Inpatient management of diabetic foot problems NHS March 2011"},{"key":"10.1002\/14651858.CD009061.pub2-BIB0094|cit94","volume-title":"Antimicrobial resistance: global report on surveillance","volume":"ISBN 978 92 4 1","author":"World Health Organization","year":"2014"},{"key":"10.1002\/14651858.CD009061.pub2-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1002\/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8","article-title":"Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints","volume":"17","author":"Parmar","year":"1998","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD009061.pub2-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"513","DOI":"10.2337\/diacare.13.5.513","article-title":"Pathways to diabetic limb amputation: basis for prevention","volume":"13","author":"Pecoraro","year":"1990","journal-title":"Diabetes Care"},{"key":"10.1002\/14651858.CD009061.pub2-BIB0097|cit97","first-page":"18","article-title":"High prevalence of ischaemia, infection and serious comorbidity in patients with diabetic foot disease in Europe. Baseline results from the Eurodiale study","volume":"1","author":"Prompers","journal-title":"2007"},{"key":"10.1002\/14651858.CD009061.pub2-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1007\/s00125-008-1089-6","article-title":"Resource utilisation and costs associated with the treatment of diabetic foot ulcers. Prospective data from the Eurodiale Study","volume":"10","author":"Prompers","year":"2008","journal-title":"Diabetologia"},{"issue":"6","key":"10.1002\/14651858.CD009061.pub2-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1053\/j.jfas.2014.06.011","article-title":"Self-reported quality of life and diabetic foot infections","volume":"53","author":"Raspovic","year":"2014","journal-title":"Journal of Foot and Ankle Surgery"},{"issue":"3","key":"10.1002\/14651858.CD009061.pub2-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1001\/archsurg.1949.01240040602023","article-title":"Reduction in mortality and loss of limbs in diabetic gangrene and infection","volume":"59","author":"Regan","year":"1949","journal-title":"Archives of Surgery"},{"key":"10.1002\/14651858.CD009061.pub2-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2337\/diacare.22.1.157","article-title":"Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings","volume":"22","author":"Reiber","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1002\/14651858.CD009061.pub2-BIB0102|cit102","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014"},{"key":"10.1002\/14651858.CD009061.pub2-BIB0103|cit103","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD009061","article-title":"Systemic antibiotics for treating diabetic foot infections","author":"Selva","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD009061.pub2-BIB0104|cit104","unstructured":"Scottish Intercollegiate Guidelines Network (SIGN) Search filters http:\/\/www.sign.ac.uk\/methodology\/filters.html#random (accessed \u00a028 January 2011)"},{"key":"10.1002\/14651858.CD009061.pub2-BIB0105|cit105","doi-asserted-by":"crossref","unstructured":"Sterne JAC Why the Cochrane risk of bias tool should not include funding source as a standard item [editorial] Cochrane Database of Systematic Reviews 2013","DOI":"10.1002\/14651858.ED000076"},{"key":"10.1002\/14651858.CD009061.pub2-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1745-6215-8-16","article-title":"Practical methods for incorporating summary time-to-event data into meta-analysis","volume":"8","author":"Tierney","year":"2007","journal-title":"Trials"},{"issue":"11","key":"10.1002\/14651858.CD009061.pub2-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1093\/ajhp\/52.11.1199","article-title":"Systemic antimicrobial treatment of foot infections in diabetic patients","volume":"52","author":"West","year":"1995","journal-title":"American Journal of Health-System Pharmacy"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD009061.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T04:51:06Z","timestamp":1634273466000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD009061.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Wounds Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,9,4]]},"references-count":107,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2015,9]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd009061.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,4]]}}}